FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

India’s education minister resigns after student protests over medical exam leaks

EXCLUSIVE: Alleged $32M COVID-19 fraud fugitive captured in Jamaica and returned to US, FBI says

Court checks Pritzker as Trump administration scores another immigration win

NYC 5-alarm fire injures at least 17 firefighters, others as blaze damages multiple apartment buildings

Katy Perry ‘appalled’ to see her song used on White House TikTok account

Biden judge blocking Ethiopian deportations despite SCOTUS ruling clashed with ICE before

Fewer Gay Professionals Feel Being Gay Helps Their Career

Trump defends New York Times subpoenas as judge seeks internal DOJ communications

State Officials Blamed Citizens for Death of Bear Stuck Atop Power Pole, but What Bystander Says She Saw Changes Everything

Maine Democrats crown Troy Jackson as Platner replacement as fresh scrutiny clouds Senate reset

Pentagon Official Calls Ex-White House AI Architect ‘Village Idiot’ in China Policy Spat

ICE Deports Ex-NFL Linebacker and Rugby Star: Report

Media’s WNBA Madness: Days After Article Linking Caitlin Clark With Lynching, USA Today Makes Another Huge Clark-Related Reporting Blunder

Brian Hooker’s stepmom wants to help investigators as she suspects he ‘lied about everything’: reports

Another 20 Christians Slaughtered in Nigeria Attack

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”